NEW YORK--(BUSINESS WIRE)--NeoStem, Inc. (AMEX:NBS), a leading-edge biotechnology services company capitalizing on breakthroughs in the burgeoning field of adult stem cell therapeutics, has signed an agreement with Stem Cell Collect, LLC. The multi-territory development agreement signals a business development milestone for NeoStem as it seeks to quickly and efficiently penetrate additional metropolitan areas as a means to opening new revenue opportunities.
